Maeva Charkaoui
Montfermeil, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Real world experience with granulocyte and monocyte adsorptive apheresis (ADACOLUMN®) in patients with refractory inflammatory bowel disease: a retrospective observational multicenter cohort study.
Journal: Clinics and research in hepatology and gastroenterology
Published: May 28, 2026
Association of bowel urgency, disease activity and disability in patients with inflammatory bowel disease: A cross-sectional study from the GETAID.
Journal: Clinics and research in hepatology and gastroenterology
Published: May 08, 2026
Association between physical activity with disease activity and functional disability in patients with inflammatory bowel disease.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: November 30, 2025
Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID.
Journal: United European gastroenterology journal
Published: October 19, 2025
Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID.
Journal: United European gastroenterology journal
Published: October 19, 2025
Diet and clinical remission in patients with inflammatory bowel disease: A multicenter cross-sectional study.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: October 07, 2025
Endoscopic submucosal dissection for visible dysplasia in inflammatory bowel disease: a nationwide multicenter cohort from the GETAID and the SFED.
Journal: Journal of Crohn's & colitis
Published: April 25, 2025
Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study.
Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study.
Journal: Alimentary pharmacology & therapeutics
Published: March 31, 2025
TNF Inhibitor-Induced Sarcoidosis-Like Lesions in Inflammatory Bowel Disease.
Journal: United European gastroenterology journal
Published: December 13, 2024
Subcutaneous Infliximab for Perianal Crohn's Disease: The BioLap-Rem Multicenter Study From the GETAID.
Journal: The American journal of gastroenterology
Published: December 10, 2024
Tofacitinib for Patients with Anti-TNF Refractory Ulcerative Proctitis: A Multicentre Cohort Study from the GETAID.
Journal: Journal of Crohn's & colitis
Published: June 16, 2023
Impact of Anti-tumour Necrosis Factor Agents on the Risk of Colorectal Cancer in Patients with Ulcerative Colitis: Nationwide French Cohort Study.
Journal: Journal of Crohn's & colitis
Published: October 18, 2021
Last Updated: 09/26/2026